Online peptide seller sentenced to nearly 6 years in prison

A federal judge has sentenced Matthew Kawa, the owner of Paradigm Peptides, to 70 months in prison for building a large business through deception and selling adulterated products, including steroids. U.S. District Court Judge Cristal Brisco criticized Kawa for prioritizing business growth over customer well-being, noting his disregard for regulatory warnings and the "trail of harm" left behind.

“

You focused on what you wanted to build instead of thinking about the people.

Paradigm Peptides, which served an estimated 54,000 customers across the U.S. and 80 countries, operated in the largely unregulated market of research chemicals. The company imported peptides from countries like China and India, and Kawa admitted to forging laboratory certificates to enhance credibility. Prosecutors revealed that six compounds intended to mimic testosterone actually contained the hormone, which is strictly regulated due to health risks.

“

I'm deeply sorry I betrayed that trust. I should have asked harder questions and made sure what we did followed the law.

Kawa, 48, pleaded guilty last year to selling unapproved drugs and illegally importing them. He acknowledged in his plea deal that he knew Paradigm's products were marketed for human consumption, despite the "for research use only" disclaimer. He agreed to forfeit $5 million in business proceeds. His sister and employee, Jennifer Stechkober, 32, was sentenced to 16 months for her integral role in the company's operations and false statements.

“

I knew that Paradigm's products were being marketed and sold for human consumption.